Key result
The truncated abstract provides no results, only discussing the logistical challenges of obtaining human immune serum for the early treatment of poliomyelitis.
Discusses the logistical challenges of obtaining convalescent serum for poliomyelitis and proposes transfusion donors as an alternative source.
Answers are grounded in this paper and cite their sources.
Supply constraints limit convalescent serum for poliomyelitis; leaves open donor transfusion strategies for future outbreaks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Harold K. Faber (1931) studied Poliomyelitis. Human immune serum was evaluated. The truncated abstract provides no results, only discussing the logistical challenges of obtaining human immune serum for the early treatment of poliomyelitis.
Synapse has enriched 10 related papers. Consider them for comparative context: